Zi Long Qian
Vorstandsvorsitzender bei SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.
Vermögen: 177 726 $ am 30.04.2024
Profil
Zi Long Qian is currently the Director at Wuhan Huayang Animal Pharmaceutical Co., Ltd.
and the General Manager at Shenzhen Kingsino Technology Co., Ltd.
He has an undergraduate degree from China University of Geosciences and an MBA from Sun Yat-Sen University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.08.2023 | 292 500 ( 0,05% ) | 177 726 $ | 30.04.2024 |
Aktive Positionen von Zi Long Qian
| Unternehmen | Position | Beginn |
|---|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Vorstandsvorsitzender | 28.10.2022 |
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
 Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Direktor/Vorstandsmitglied | - |
Ausbildung von Zi Long Qian
| China University of Geosciences | Undergraduate Degree |
| Sun Yat-Sen University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Health Technology |
